Pharmaceutical Contract Packaging Market
Description
Pharmaceutical Contract Packaging Market Snapshot: Market Size, CAGR, and Growth Outlook to 2032
Global Pharmaceutical Contract Packaging Market Size is projected to hit $58.2 Billion in 2032 at a CAGR of 6.2% from $38.2 Billion in 2025.
The Pharmaceutical Contract Packaging Market report provides detailed analysis and outlook of Pharmaceutical Contract Packaging Market segments including By Service Type (Primary Packaging, Secondary Packaging, Tertiary Packaging, By Packaging Format (Blister Packs, Bottles, Vials and Ampoules, Pre-filled Syringes and Cartridges, Sachets and Stick Packs, Punches and Pouches, By Material Type (Plastics and Polymers, Paper and Paperboard, Glass, Aluminum Foil, Other Materials, By Drug Formulation (Solid Dosage, Liquid Dosage, Injectable / Parenteral, Semi-Solid Dosage, By End-User (Big Pharma, Generics and Biosimilar Companies, Emerging Biotech and Start-ups, CROs and CDMOs) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
The Pharmaceutical Contract Packaging Market at a Glance (2026)
AI-Driven Traceability Systems and Automation in Packaging Operations
The pharmaceutical contract packaging market in 2026 is increasingly defined by digital transformation and the integration of advanced traceability technologies. As global track-and-trace regulations reach final enforcement stages, contract development and manufacturing organizations are adopting AI-powered vision systems to ensure accuracy and compliance in labeling and packaging processes.
These systems utilize machine learning algorithms and high-resolution imaging to detect labeling errors, verify serialization codes, and ensure consistency across packaging lines. By automating quality control processes, manufacturers are reducing reliance on manual inspection, minimizing human error, and improving overall operational efficiency.
The integration of digital traceability systems extends beyond packaging lines into supply chain management. Serialized data is being captured and analyzed in real time, enabling end-to-end visibility of product movement. This capability is critical for compliance with regulatory requirements and for maintaining product integrity throughout distribution.
Intelligent Cold Chain Solutions and Strategic Outsourcing Models
A parallel trend in 2026 is the convergence of contract packaging with advanced cold chain logistics, particularly for temperature-sensitive biologics. IoT-enabled intelligent shipping solutions have become standard in the industry, providing real-time monitoring of temperature, humidity, and location during transit.
These intelligent shippers are equipped with sensors and communication technologies that transmit data continuously, allowing operators to detect and respond to temperature excursions before they compromise product quality. This level of control is essential for high-value biologics, where even minor deviations can result in significant financial and clinical impact.
Strategic outsourcing is also gaining momentum as pharmaceutical companies seek to focus on core research and development activities. Collaborations such as the expanded partnership between Eli Lilly and Cambrex highlight a broader industry trend toward leveraging specialized expertise in packaging and logistics.
By outsourcing complex and temperature-sensitive packaging operations to dedicated partners, pharmaceutical companies can access advanced infrastructure, technical expertise, and regulatory compliance capabilities without significant capital investment. This approach enhances operational flexibility and allows for more efficient scaling of clinical and commercial supply chains.
The increasing reliance on digital tools, intelligent logistics systems, and specialized service providers is redefining the pharmaceutical contract packaging landscape, aligning it with the demands of modern biopharmaceutical production and distribution.
Global Pharmaceutical Contract Packaging Market Dynamics: Growth Drivers, Restraints, and Opportunities
Strategic Market Drivers: What’s Fueling Growth in 2026?
The Pharmaceutical Contract Packaging Market report provides a comprehensive assessment of the structural and technical factors shaping the market’s evolution in 2026 and beyond. It evaluates demand-side shifts, supply-side constraints, regulatory influences, and technology-led disruption impacting both established players and new market entrants. The Pharmaceutical Contract Packaging Market analysis details the impact of changing end-use requirements, evolving customer specifications, and increasing performance expectations across countries. Further, key drivers and opportunities are mapped across regional and application-level dynamics.
Profit Prioritization and Portfolio Rebalancing
Asset Rationalization: Tier 1 players are aggressively divesting low-margin, commoditized assets to reallocate capital toward high-purity, differentiated offerings with superior pricing power.
Operating Leverage: Amidst persistent raw material volatility, companies are leveraging Digital Twins and AI-driven manufacturing to optimize OpEx.
Specialty Transition: Strategic investments are now concentrated in high-growth niches where customized formulations and technical barriers to entry protect EBITDA margins from global overcapacity in basic chemicals.
A Deep Dive into Emerging Market Hubs
Rapid economic growth, coupled with demand for Pharmaceutical Contract Packaging Market are driving the investment focus on these markets. In particular, India, China, Southeast Asia, Brazil, Eastern Europe, and Latin American markets are registering higher than the global average growth rate. The urban population is expected to reach 6 billion by 2045, around 1.3 times the surge from 2023 levels. Rapid industrialization, infrastructure development, urbanization, and expanding domestic consumption are driving above-average demand growth across markets. Leading Pharmaceutical Contract Packaging Market companies are accelerating investments in local manufacturing, regional supply chains, and application-specific product development to capture these opportunities.
Emerging Opportunities: Untapped High-Growth Niches in the Post-Pandemic Recovery
The post-pandemic landscape for the chemical industry shifted from crisis management to strategic opportunity. In 2026, leading companies are focused on supply chain regionalization, the hygiene-sustainability nexus, and the digital leap in R&D. The Pharmaceutical Contract Packaging Market is witnessing the emergence of niche, high-growth segments driven by evolving customer needs and regulatory drive. Demand for customized formulations, performance-enhancing solutions, and application-specific variants is rising across advanced manufacturing, specialty end-use industries, and sustainability-led applications. The report identifies underpenetrated segments where innovation, technical differentiation, and faster go-to-market strategies can unlock disproportionate value.
Pharmaceutical Contract Packaging Market Challenge- Impact of Geopolitical Uncertainty on Market Stability
In 2026, geopolitical risk has become a structural variable shaping the Pharmaceutical Contract Packaging Market rather than a short-term disruption factor. Ongoing trade realignments between the U.S., China, and the EU, coupled with sanctions regimes, export controls, and industrial policy interventions, are directly influencing sourcing strategies, production footprints, and pricing stability across the Pharmaceutical Contract Packaging Market value chain. Regional disparities in energy pricing, port congestion risks, and shipping route instability are creating uneven cost structures among global Pharmaceutical Contract Packaging Market producers. Accordingly, Pharmaceutical Contract Packaging Market companies with regionally diversified production assets and localized supplier ecosystems are demonstrating higher margin stability compared to export-reliant peers.
Pharmaceutical Contract Packaging Market Strategic Assessment: SWOT, Five Forces, and Value Chain Analysis
Scenario analysis
Amidst varying regulations, trade patterns, supply chain dynamics, and market dynamics, the scenario analysis allows firms to stress-test their current business models. The chapter provides three distinct ‘What-If’ pathways for the Pharmaceutical Contract Packaging Market through 2032- high growth, low growth, and reference cases. The detailed forward-looking assessment ensures that strategic decisions made today remain viable across a range of potential economic and regulatory outcomes.
Value Chain Analysis
The report identifies key players across the Pharmaceutical Contract Packaging Industry value chain, tracing the flow from procurement to end-user. By understanding supplier dependencies, processing intensity, distribution dynamics, and customer power at each stage, stakeholders can identify opportunities for vertical integration, strategic partnerships, localization, or operational optimization.
Porter’s Five Forces Analysis
The Porter’s Five Forces analysis chapter incorporates quantitative scoring and weighted impact evaluation for each competitive force within the Pharmaceutical Contract Packaging Market. This section helps objectively measure industry attractiveness, margin sustainability, and competitive risk using a standardized analytical framework. Companies can evaluate the bargaining power of suppliers and buyers, the threat of substitutes and new entrants, and the degree of rivalry among existing players.
Market Segmentation: Historical and Projected Market Revenue Forecast
Revenue Growth Strategies for Pharmaceutical Contract Packaging Market Segments
The report provides the Pharmaceutical Contract Packaging Market size across By Service Type (Primary Packaging, Secondary Packaging, Tertiary Packaging, By Packaging Format (Blister Packs, Bottles, Vials and Ampoules, Pre-filled Syringes and Cartridges, Sachets and Stick Packs, Punches and Pouches, By Material Type (Plastics and Polymers, Paper and Paperboard, Glass, Aluminum Foil, Other Materials, By Drug Formulation (Solid Dosage, Liquid Dosage, Injectable / Parenteral, Semi-Solid Dosage, By End-User (Big Pharma, Generics and Biosimilar Companies, Emerging Biotech and Start-ups, CROs and CDMOs). Market size outlook across the segments is provided at the global, North America, Europe, Asia Pacific, South and Central America, and the Middle East and African regions. Across each segment, the report analyzes the growth prospects, post-pandemic recovery, and country-specific dynamics.
Regional Outlook for Pharmaceutical Contract Packaging Market Manufacturers
United States Pharmaceutical Contract Packaging Market Size and Share Analysis- Evolving Trade Policies and Supply Chain Reshuffling
The United States Pharmaceutical Contract Packaging Market is being reshaped by evolving trade policies, industrial localization initiatives, and a reconfiguration of global supply chains. The outlook for 2026 is moderately higher relative to 2025, driven by policy-driven sourcing decisions, domestic manufacturing incentives, and strategic supplier realignment.
Global GDP forecasts fell to 3.0% in 2025 and 3.1% in 2026, with US growth slowing to 1.8% and 1.4%, respectively. Tariffs on critical intermediates have added around 0.5 percentage points to core inflation, squeezing the margins of downstream manufacturers. Similarly, an estimated 20% of manufacturers are likely to deploy physical AI to mitigate labor shortages in the US. Over the forecast period, as domestic pricing, margin profiles, and capacity utilization increasingly correlate with U.S.-specific trade exposure, logistics costs, and policy alignment, companies focus significantly on supply-chain optimization.
Canada Pharmaceutical Contract Packaging Industry Forecast 2026–2032- Increasing role in North America Supply Chain realignment
Canada’s real GDP growth is projected to average 1.25% to 1.5% in 2026, a modest recovery from the 1.3% growth seen in 2025. Unlike the high-volume commodity focus of previous decades, the current market is driven by high-value specialty segments. Strong end-user demand from Ontario, Alberta, Quebec, British Columbia, and other provinces is shaping the long-term growth strategies. The report analyzes the key market drivers and provides the Canada Pharmaceutical Contract Packaging Market size outlook over the forecast period to 2032.
Mexico Pharmaceutical Contract Packaging Market - Companies are investing in Nearshoring hubs
Nearshoring into Mexico and Canada is accelerating, with the US-Mexico trade projected to grow by $315 Billion by the end of the decade. The American Chemistry Council (ACC), the National Association of the Chemical Industry of Mexico (ANIQ), and the Chemistry Industry Association of Canada (CIAC) are focusing on renewal and strengthening the USMCA. Geographic proximity to the United States enables just-in-time supply models, making Mexico a strategic production location for downstream chemical derivatives, resin conversion, coatings, adhesives, and formulation-based specialty products.
Germany Continues to Dominate the European Pharmaceutical Contract Packaging Industry
German giants are divesting non-core assets and emphasizing specialized applications, technical precision, and high-value customer solutions. For instance, Henkel’s $2.5 billion acquisition of Stahl Holdings in February 2026. Leading Pharmaceutical Contract Packaging Market companies are formulating strategies to mitigate short-term effects, including supply chain disruptions and destocking, and longer-term structural dynamics. Over the long-term future, demand outlook remains steady across key value chains, driving investments in new product launches and widening distribution channels.
UK- Post-Brexit Divergence and Specialized Clusters
The United Kingdom chemical industry in 2026 is shaped by divergent structural forces combining cost pressure with specialization-driven resilience. European natural gas prices remain structurally around 3.5× higher than U.S. levels, constraining energy-intensive bulk chemical economics and accelerating a pivot toward higher-value specialty chemicals, performance materials, and formulation-led production. Industry restructuring across the region is evident, with chemical plant closures in Europe increasing sixfold since 2022, according to Cefic, reinforcing the UK sector’s move away from commodity exposure toward efficiency-focused, technology-enabled operations. At the same time, logistics capacity is expanding, with the UK chemical logistics market growing at roughly 5% annually to reach about $8 billion in 2026, strengthening the country’s role as a storage, distribution, and re-export hub for specialty and regulated chemical flows.
China and India account for over 40% of global demand
China’s Pharmaceutical Contract Packaging Industry is witnessing rapid capacity expansion, technology-led upgrading, and demand reorientation, with accelerated investment across value chain segments reshaping competitive dynamics. The $1.5 trillion chemical industry remains a primary engine of GDP growth, with a government-mandated target of 5% average annual growth in industrial added value through year-end 2026.
Demand fundamentals are also shifting structurally: by 2030, China and India together are projected to account for 40% of global middle-class consumption, up from less than 10% in 2010, indicating long-term expansion in consumption-driven Pharmaceutical Contract Packaging Market applications. Among end-user markets, Guangdong, Jiangsu, Shandong, Zhejiang, Sichuan, and others are widely focused on by vendors.
India remains a significant outlier with a projected 6.6% GDP growth in 2026, driving a surge in Pharmaceutical Contract Packaging Market demand. The government's $1.4 trillion National Infrastructure Pipeline is a massive driver for the market outlook. The Indian government is expected to expand the Production Linked Incentive (PLI) scheme for specialty chemicals in 2026.
Japan: Maintaining Dominance in High-Performance Segments
Japan’s Pharmaceutical Contract Packaging Industry in 2026 is concentrated in high-performance, specification-critical segments where technical qualification barriers protect margins. Japan’s chemical sector remains one of the world’s most innovation-dense. In 2026, R&D spending in the sector continues to exceed $2.1 Billion annually, with Tokyo and the Kanto region serving as the global hubs for research. Persistent public-sector funding worth ¥4 trillion has moved capital toward advanced materials. To sustain competitive positioning in the evolving environment, Japanese firms can unlock growth by developing new markets through business model transformation and differentiated customer engagement strategies, reflecting the industry’s shift beyond product-led competition toward solution-oriented value creation.
Southeast Asia: The New Manufacturing Core
Southeast Asia is emerging as a primary manufacturing and chemical production growth zone, supported by industrial policy, infrastructure expansion, and supply chain diversification. Vietnam is advancing sector expansion under its Chemical Industry Development Strategy 2030, targeting average annual industry growth of 10–11% through 2030, with emphasis on petrochemicals, downstream plastics, industrial chemicals, and specialty materials serving electronics, construction, and export manufacturing.
The regional economy continues to be resilient, adapting to the shifting landscape and with momentum varying across countries and sectors. Concurrently, Indonesia is accelerating industrial capacity through its National Medium-Term Development Plan (RPJMN), which includes $414 billion in infrastructure investment, strengthening ports, energy systems, and industrial corridors critical for chemical logistics and processing industries.
Middle East- Rapid Economic Growth Supports Potential Business Expansion Opportunities
The Middle East chemical industry is strengthening its position as a global production and export hub through sustained capital deployment, feedstock integration, and downstream diversification. Between 2023 and the end of 2026, the region is tracking around 160 capital projects valued at more than $55 billion, reflecting continued investment in petrochemicals, polymers, specialty derivatives, and industrial chemicals.
The regulatory environment has become increasingly fragmented across geographies. Abundant hydrocarbon feedstocks, integrated refinery-petrochemical complexes, and export-oriented infrastructure provide structural cost advantages that support both commodity and higher-value chemical chains. In Saudi Arabia, the National Industry Strategy targets a fourfold increase in downstream chemical output by 2035, signaling a shift from base petrochemical exports toward specialty materials, performance polymers, and conversion industries.
Competitive Analysis- Intensity of Competition and Market Share
Companies are increasing R&D expenditures by 2-3% while high-intensity segments are witnessing an 8-9% increase in expenditure. The global Pharmaceutical Contract Packaging Industry is characterized by intense competition with companies focusing on profit margins through widening end-user applications. Leading companies, including Catalent, Inc., Thermo Fisher Scientific (Patheon), Lonza Group, Sharp (UPMC Group), Nipro Corporation, Pfizer CentreOne, Recipharm AB, Vetter Pharma, Almac Group, PCI Pharma Services, are analyzed in the study. For each company, a detailed business description, SWOT profile, and products and services benchmarking are provided.
Pharmaceutical Contract Packaging Market Segmentation
By Service Type
Primary Packaging
Secondary Packaging
Tertiary Packaging
By Packaging Format
Blister Packs
Bottles
Vials and Ampoules
Pre-filled Syringes and Cartridges
Sachets and Stick Packs
Punches and Pouches
By Material Type
Plastics and Polymers
Paper and Paperboard
Glass
Aluminum Foil
Other Materials
By Drug Formulation
Solid Dosage
Liquid Dosage
Injectable / Parenteral
Semi-Solid Dosage
By End-User
Big Pharma
Generics and Biosimilar Companies
Emerging Biotech and Start-ups
CROs and CDMOs
Top companies in the Pharmaceutical Contract Packaging Industry
Catalent, Inc.
Thermo Fisher Scientific (Patheon)
Lonza Group
Sharp (UPMC Group)
Nipro Corporation
Pfizer CentreOne
Recipharm AB
Vetter Pharma
Almac Group
PCI Pharma Services
Countries Included
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, Others
Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Global Pharmaceutical Contract Packaging Market Size is projected to hit $58.2 Billion in 2032 at a CAGR of 6.2% from $38.2 Billion in 2025.
The Pharmaceutical Contract Packaging Market report provides detailed analysis and outlook of Pharmaceutical Contract Packaging Market segments including By Service Type (Primary Packaging, Secondary Packaging, Tertiary Packaging, By Packaging Format (Blister Packs, Bottles, Vials and Ampoules, Pre-filled Syringes and Cartridges, Sachets and Stick Packs, Punches and Pouches, By Material Type (Plastics and Polymers, Paper and Paperboard, Glass, Aluminum Foil, Other Materials, By Drug Formulation (Solid Dosage, Liquid Dosage, Injectable / Parenteral, Semi-Solid Dosage, By End-User (Big Pharma, Generics and Biosimilar Companies, Emerging Biotech and Start-ups, CROs and CDMOs) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
The Pharmaceutical Contract Packaging Market at a Glance (2026)
AI-Driven Traceability Systems and Automation in Packaging Operations
The pharmaceutical contract packaging market in 2026 is increasingly defined by digital transformation and the integration of advanced traceability technologies. As global track-and-trace regulations reach final enforcement stages, contract development and manufacturing organizations are adopting AI-powered vision systems to ensure accuracy and compliance in labeling and packaging processes.
These systems utilize machine learning algorithms and high-resolution imaging to detect labeling errors, verify serialization codes, and ensure consistency across packaging lines. By automating quality control processes, manufacturers are reducing reliance on manual inspection, minimizing human error, and improving overall operational efficiency.
The integration of digital traceability systems extends beyond packaging lines into supply chain management. Serialized data is being captured and analyzed in real time, enabling end-to-end visibility of product movement. This capability is critical for compliance with regulatory requirements and for maintaining product integrity throughout distribution.
Intelligent Cold Chain Solutions and Strategic Outsourcing Models
A parallel trend in 2026 is the convergence of contract packaging with advanced cold chain logistics, particularly for temperature-sensitive biologics. IoT-enabled intelligent shipping solutions have become standard in the industry, providing real-time monitoring of temperature, humidity, and location during transit.
These intelligent shippers are equipped with sensors and communication technologies that transmit data continuously, allowing operators to detect and respond to temperature excursions before they compromise product quality. This level of control is essential for high-value biologics, where even minor deviations can result in significant financial and clinical impact.
Strategic outsourcing is also gaining momentum as pharmaceutical companies seek to focus on core research and development activities. Collaborations such as the expanded partnership between Eli Lilly and Cambrex highlight a broader industry trend toward leveraging specialized expertise in packaging and logistics.
By outsourcing complex and temperature-sensitive packaging operations to dedicated partners, pharmaceutical companies can access advanced infrastructure, technical expertise, and regulatory compliance capabilities without significant capital investment. This approach enhances operational flexibility and allows for more efficient scaling of clinical and commercial supply chains.
The increasing reliance on digital tools, intelligent logistics systems, and specialized service providers is redefining the pharmaceutical contract packaging landscape, aligning it with the demands of modern biopharmaceutical production and distribution.
Global Pharmaceutical Contract Packaging Market Dynamics: Growth Drivers, Restraints, and Opportunities
Strategic Market Drivers: What’s Fueling Growth in 2026?
The Pharmaceutical Contract Packaging Market report provides a comprehensive assessment of the structural and technical factors shaping the market’s evolution in 2026 and beyond. It evaluates demand-side shifts, supply-side constraints, regulatory influences, and technology-led disruption impacting both established players and new market entrants. The Pharmaceutical Contract Packaging Market analysis details the impact of changing end-use requirements, evolving customer specifications, and increasing performance expectations across countries. Further, key drivers and opportunities are mapped across regional and application-level dynamics.
Profit Prioritization and Portfolio Rebalancing
Asset Rationalization: Tier 1 players are aggressively divesting low-margin, commoditized assets to reallocate capital toward high-purity, differentiated offerings with superior pricing power.
Operating Leverage: Amidst persistent raw material volatility, companies are leveraging Digital Twins and AI-driven manufacturing to optimize OpEx.
Specialty Transition: Strategic investments are now concentrated in high-growth niches where customized formulations and technical barriers to entry protect EBITDA margins from global overcapacity in basic chemicals.
A Deep Dive into Emerging Market Hubs
Rapid economic growth, coupled with demand for Pharmaceutical Contract Packaging Market are driving the investment focus on these markets. In particular, India, China, Southeast Asia, Brazil, Eastern Europe, and Latin American markets are registering higher than the global average growth rate. The urban population is expected to reach 6 billion by 2045, around 1.3 times the surge from 2023 levels. Rapid industrialization, infrastructure development, urbanization, and expanding domestic consumption are driving above-average demand growth across markets. Leading Pharmaceutical Contract Packaging Market companies are accelerating investments in local manufacturing, regional supply chains, and application-specific product development to capture these opportunities.
Emerging Opportunities: Untapped High-Growth Niches in the Post-Pandemic Recovery
The post-pandemic landscape for the chemical industry shifted from crisis management to strategic opportunity. In 2026, leading companies are focused on supply chain regionalization, the hygiene-sustainability nexus, and the digital leap in R&D. The Pharmaceutical Contract Packaging Market is witnessing the emergence of niche, high-growth segments driven by evolving customer needs and regulatory drive. Demand for customized formulations, performance-enhancing solutions, and application-specific variants is rising across advanced manufacturing, specialty end-use industries, and sustainability-led applications. The report identifies underpenetrated segments where innovation, technical differentiation, and faster go-to-market strategies can unlock disproportionate value.
Pharmaceutical Contract Packaging Market Challenge- Impact of Geopolitical Uncertainty on Market Stability
In 2026, geopolitical risk has become a structural variable shaping the Pharmaceutical Contract Packaging Market rather than a short-term disruption factor. Ongoing trade realignments between the U.S., China, and the EU, coupled with sanctions regimes, export controls, and industrial policy interventions, are directly influencing sourcing strategies, production footprints, and pricing stability across the Pharmaceutical Contract Packaging Market value chain. Regional disparities in energy pricing, port congestion risks, and shipping route instability are creating uneven cost structures among global Pharmaceutical Contract Packaging Market producers. Accordingly, Pharmaceutical Contract Packaging Market companies with regionally diversified production assets and localized supplier ecosystems are demonstrating higher margin stability compared to export-reliant peers.
Pharmaceutical Contract Packaging Market Strategic Assessment: SWOT, Five Forces, and Value Chain Analysis
Scenario analysis
Amidst varying regulations, trade patterns, supply chain dynamics, and market dynamics, the scenario analysis allows firms to stress-test their current business models. The chapter provides three distinct ‘What-If’ pathways for the Pharmaceutical Contract Packaging Market through 2032- high growth, low growth, and reference cases. The detailed forward-looking assessment ensures that strategic decisions made today remain viable across a range of potential economic and regulatory outcomes.
Value Chain Analysis
The report identifies key players across the Pharmaceutical Contract Packaging Industry value chain, tracing the flow from procurement to end-user. By understanding supplier dependencies, processing intensity, distribution dynamics, and customer power at each stage, stakeholders can identify opportunities for vertical integration, strategic partnerships, localization, or operational optimization.
Porter’s Five Forces Analysis
The Porter’s Five Forces analysis chapter incorporates quantitative scoring and weighted impact evaluation for each competitive force within the Pharmaceutical Contract Packaging Market. This section helps objectively measure industry attractiveness, margin sustainability, and competitive risk using a standardized analytical framework. Companies can evaluate the bargaining power of suppliers and buyers, the threat of substitutes and new entrants, and the degree of rivalry among existing players.
Market Segmentation: Historical and Projected Market Revenue Forecast
Revenue Growth Strategies for Pharmaceutical Contract Packaging Market Segments
The report provides the Pharmaceutical Contract Packaging Market size across By Service Type (Primary Packaging, Secondary Packaging, Tertiary Packaging, By Packaging Format (Blister Packs, Bottles, Vials and Ampoules, Pre-filled Syringes and Cartridges, Sachets and Stick Packs, Punches and Pouches, By Material Type (Plastics and Polymers, Paper and Paperboard, Glass, Aluminum Foil, Other Materials, By Drug Formulation (Solid Dosage, Liquid Dosage, Injectable / Parenteral, Semi-Solid Dosage, By End-User (Big Pharma, Generics and Biosimilar Companies, Emerging Biotech and Start-ups, CROs and CDMOs). Market size outlook across the segments is provided at the global, North America, Europe, Asia Pacific, South and Central America, and the Middle East and African regions. Across each segment, the report analyzes the growth prospects, post-pandemic recovery, and country-specific dynamics.
Regional Outlook for Pharmaceutical Contract Packaging Market Manufacturers
United States Pharmaceutical Contract Packaging Market Size and Share Analysis- Evolving Trade Policies and Supply Chain Reshuffling
The United States Pharmaceutical Contract Packaging Market is being reshaped by evolving trade policies, industrial localization initiatives, and a reconfiguration of global supply chains. The outlook for 2026 is moderately higher relative to 2025, driven by policy-driven sourcing decisions, domestic manufacturing incentives, and strategic supplier realignment.
Global GDP forecasts fell to 3.0% in 2025 and 3.1% in 2026, with US growth slowing to 1.8% and 1.4%, respectively. Tariffs on critical intermediates have added around 0.5 percentage points to core inflation, squeezing the margins of downstream manufacturers. Similarly, an estimated 20% of manufacturers are likely to deploy physical AI to mitigate labor shortages in the US. Over the forecast period, as domestic pricing, margin profiles, and capacity utilization increasingly correlate with U.S.-specific trade exposure, logistics costs, and policy alignment, companies focus significantly on supply-chain optimization.
Canada Pharmaceutical Contract Packaging Industry Forecast 2026–2032- Increasing role in North America Supply Chain realignment
Canada’s real GDP growth is projected to average 1.25% to 1.5% in 2026, a modest recovery from the 1.3% growth seen in 2025. Unlike the high-volume commodity focus of previous decades, the current market is driven by high-value specialty segments. Strong end-user demand from Ontario, Alberta, Quebec, British Columbia, and other provinces is shaping the long-term growth strategies. The report analyzes the key market drivers and provides the Canada Pharmaceutical Contract Packaging Market size outlook over the forecast period to 2032.
Mexico Pharmaceutical Contract Packaging Market - Companies are investing in Nearshoring hubs
Nearshoring into Mexico and Canada is accelerating, with the US-Mexico trade projected to grow by $315 Billion by the end of the decade. The American Chemistry Council (ACC), the National Association of the Chemical Industry of Mexico (ANIQ), and the Chemistry Industry Association of Canada (CIAC) are focusing on renewal and strengthening the USMCA. Geographic proximity to the United States enables just-in-time supply models, making Mexico a strategic production location for downstream chemical derivatives, resin conversion, coatings, adhesives, and formulation-based specialty products.
Germany Continues to Dominate the European Pharmaceutical Contract Packaging Industry
German giants are divesting non-core assets and emphasizing specialized applications, technical precision, and high-value customer solutions. For instance, Henkel’s $2.5 billion acquisition of Stahl Holdings in February 2026. Leading Pharmaceutical Contract Packaging Market companies are formulating strategies to mitigate short-term effects, including supply chain disruptions and destocking, and longer-term structural dynamics. Over the long-term future, demand outlook remains steady across key value chains, driving investments in new product launches and widening distribution channels.
UK- Post-Brexit Divergence and Specialized Clusters
The United Kingdom chemical industry in 2026 is shaped by divergent structural forces combining cost pressure with specialization-driven resilience. European natural gas prices remain structurally around 3.5× higher than U.S. levels, constraining energy-intensive bulk chemical economics and accelerating a pivot toward higher-value specialty chemicals, performance materials, and formulation-led production. Industry restructuring across the region is evident, with chemical plant closures in Europe increasing sixfold since 2022, according to Cefic, reinforcing the UK sector’s move away from commodity exposure toward efficiency-focused, technology-enabled operations. At the same time, logistics capacity is expanding, with the UK chemical logistics market growing at roughly 5% annually to reach about $8 billion in 2026, strengthening the country’s role as a storage, distribution, and re-export hub for specialty and regulated chemical flows.
China and India account for over 40% of global demand
China’s Pharmaceutical Contract Packaging Industry is witnessing rapid capacity expansion, technology-led upgrading, and demand reorientation, with accelerated investment across value chain segments reshaping competitive dynamics. The $1.5 trillion chemical industry remains a primary engine of GDP growth, with a government-mandated target of 5% average annual growth in industrial added value through year-end 2026.
Demand fundamentals are also shifting structurally: by 2030, China and India together are projected to account for 40% of global middle-class consumption, up from less than 10% in 2010, indicating long-term expansion in consumption-driven Pharmaceutical Contract Packaging Market applications. Among end-user markets, Guangdong, Jiangsu, Shandong, Zhejiang, Sichuan, and others are widely focused on by vendors.
India remains a significant outlier with a projected 6.6% GDP growth in 2026, driving a surge in Pharmaceutical Contract Packaging Market demand. The government's $1.4 trillion National Infrastructure Pipeline is a massive driver for the market outlook. The Indian government is expected to expand the Production Linked Incentive (PLI) scheme for specialty chemicals in 2026.
Japan: Maintaining Dominance in High-Performance Segments
Japan’s Pharmaceutical Contract Packaging Industry in 2026 is concentrated in high-performance, specification-critical segments where technical qualification barriers protect margins. Japan’s chemical sector remains one of the world’s most innovation-dense. In 2026, R&D spending in the sector continues to exceed $2.1 Billion annually, with Tokyo and the Kanto region serving as the global hubs for research. Persistent public-sector funding worth ¥4 trillion has moved capital toward advanced materials. To sustain competitive positioning in the evolving environment, Japanese firms can unlock growth by developing new markets through business model transformation and differentiated customer engagement strategies, reflecting the industry’s shift beyond product-led competition toward solution-oriented value creation.
Southeast Asia: The New Manufacturing Core
Southeast Asia is emerging as a primary manufacturing and chemical production growth zone, supported by industrial policy, infrastructure expansion, and supply chain diversification. Vietnam is advancing sector expansion under its Chemical Industry Development Strategy 2030, targeting average annual industry growth of 10–11% through 2030, with emphasis on petrochemicals, downstream plastics, industrial chemicals, and specialty materials serving electronics, construction, and export manufacturing.
The regional economy continues to be resilient, adapting to the shifting landscape and with momentum varying across countries and sectors. Concurrently, Indonesia is accelerating industrial capacity through its National Medium-Term Development Plan (RPJMN), which includes $414 billion in infrastructure investment, strengthening ports, energy systems, and industrial corridors critical for chemical logistics and processing industries.
Middle East- Rapid Economic Growth Supports Potential Business Expansion Opportunities
The Middle East chemical industry is strengthening its position as a global production and export hub through sustained capital deployment, feedstock integration, and downstream diversification. Between 2023 and the end of 2026, the region is tracking around 160 capital projects valued at more than $55 billion, reflecting continued investment in petrochemicals, polymers, specialty derivatives, and industrial chemicals.
The regulatory environment has become increasingly fragmented across geographies. Abundant hydrocarbon feedstocks, integrated refinery-petrochemical complexes, and export-oriented infrastructure provide structural cost advantages that support both commodity and higher-value chemical chains. In Saudi Arabia, the National Industry Strategy targets a fourfold increase in downstream chemical output by 2035, signaling a shift from base petrochemical exports toward specialty materials, performance polymers, and conversion industries.
Competitive Analysis- Intensity of Competition and Market Share
Companies are increasing R&D expenditures by 2-3% while high-intensity segments are witnessing an 8-9% increase in expenditure. The global Pharmaceutical Contract Packaging Industry is characterized by intense competition with companies focusing on profit margins through widening end-user applications. Leading companies, including Catalent, Inc., Thermo Fisher Scientific (Patheon), Lonza Group, Sharp (UPMC Group), Nipro Corporation, Pfizer CentreOne, Recipharm AB, Vetter Pharma, Almac Group, PCI Pharma Services, are analyzed in the study. For each company, a detailed business description, SWOT profile, and products and services benchmarking are provided.
Pharmaceutical Contract Packaging Market Segmentation
By Service Type
Primary Packaging
Secondary Packaging
Tertiary Packaging
By Packaging Format
Blister Packs
Bottles
Vials and Ampoules
Pre-filled Syringes and Cartridges
Sachets and Stick Packs
Punches and Pouches
By Material Type
Plastics and Polymers
Paper and Paperboard
Glass
Aluminum Foil
Other Materials
By Drug Formulation
Solid Dosage
Liquid Dosage
Injectable / Parenteral
Semi-Solid Dosage
By End-User
Big Pharma
Generics and Biosimilar Companies
Emerging Biotech and Start-ups
CROs and CDMOs
Top companies in the Pharmaceutical Contract Packaging Industry
Catalent, Inc.
Thermo Fisher Scientific (Patheon)
Lonza Group
Sharp (UPMC Group)
Nipro Corporation
Pfizer CentreOne
Recipharm AB
Vetter Pharma
Almac Group
PCI Pharma Services
Countries Included
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, Others
Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
188 Pages
- Chapter 1- Executive Summary
- 1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2032
- 1.2. Key Industry Highlights, 2026
- 1.3. Premium Market Insights
- 1.3.1. Potential Pharmaceutical Contract Packaging Market Types and Applications
- 1.3.2. Fastest Growing Countries Over the forecast period
- 1.4. Market Scope and Segmentation
- 1.4.1. Key Market Segments
- 1.4.2. Key Countries and Regions
- 1.4.3. Top Companies in the Pharmaceutical Contract Packaging Industry
- 1.5. Macroeconomic and Demographic Outlook
- 1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
- 1.5.2. Population Forecast by Country, 2010- 2040
- 1.5.3. Inflation Trends in Leading Countries
- 1.6. Impact of Trade Policies, Regulations, and Sustainability
- 1.6.1. Trade tariffs and localization requirements
- 1.6.2. ESG and sustainability pressures
- 1.6.3. Compliance-driven structural changes in the value chain
- Chapter 2- Research Methodology
- 2.1. Report Coverage
- 2.2. Secondary Research
- 2.3. Primary Research
- 2.4. Data Triangulation
- 2.5. Market Modeling and Forecasting
- Chapter 3- Global Pharmaceutical Contract Packaging Market Dynamics: Driving the 2032 Outlook
- 3.1. An Introduction to Global Pharmaceutical Contract Packaging Markets in 2026
- 3.2. Global Historic and Forecast Pharmaceutical Contract Packaging Market Size Outlook, USD Million, 2021- 2032
- 3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2032
- 3.4. Market Dynamics
- 3.4.1. Key Pharmaceutical Contract Packaging Market Driving Forces and Their Impact on Market Outlook
- 3.4.2. Short and Long-Term Trends and Insights Shaping the Future
- 3.4.3. Potential Pharmaceutical Contract Packaging Market Opportunities for Industry Stakeholders
- 3.4.4. Potential Challenges across Pharmaceutical Contract Packaging Market Value Chain
- Chapter 4- Pharmaceutical Contract Packaging Market- Strategic Analysis Review
- 4.1. Porter’s Five Forces Analysis
- 4.1.1. Bargaining Power of Buyers
- 4.1.2. Bargaining Power of Suppliers
- 4.1.3. Threat of Substitutes
- 4.1.4. Threat of New Entrants
- 4.1.5. Intensity of Competitive Rivalry
- 4.2. Competitive Landscape
- 4.2.1. Top Companies in Pharmaceutical Contract Packaging Industry
- 4.2.2. Key Growth Strategies of Pharmaceutical Contract Packaging Market Companies
- 4.2.3. Key Success Factors
- 4.3. Value Chain Analysis
- 4.3.1. Key Value Chain Segments
- 4.3.2. Dominant players by value-chain stage
- 4.4. SWOT Analysis
- 4.4.1. Key Strengths and Opportunities
- 4.4.2. Major Weaknesses and Threats
- Chapter 5- Pharmaceutical Contract Packaging Market Outlook by Segments
- 5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2032
- 5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2032
- 5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2032
- By Service Type
- Primary Packaging
- Secondary Packaging
- Tertiary Packaging
- By Packaging Format
- Blister Packs
- Bottles
- Vials and Ampoules
- Pre-filled Syringes and Cartridges
- Sachets and Stick Packs
- Punches and Pouches
- By Material Type
- Plastics and Polymers
- Paper and Paperboard
- Glass
- Aluminum Foil
- Other Materials
- By Drug Formulation
- Solid Dosage
- Liquid Dosage
- Injectable / Parenteral
- Semi-Solid Dosage
- By End-User
- Big Pharma
- Generics and Biosimilar Companies
- Emerging Biotech and Start-ups
- CROs and CDMOs
- Chapter 6- Scenario Analysis and Outlook
- 6.1. Base Case Scenario
- 6.1.1. Definitions and Insights
- 6.1.2. Market Size Outlook to 2032
- 6.2. Low Growth Case Scenario
- 6.2.1. Definitions and Insights
- 6.2.2. Market Size Outlook to 2032
- 6.3. High Growth Case Scenario
- 6.3.1. Definitions and Insights
- 6.3.2. Market Size Outlook to 2032
- Chapter 7- North America Pharmaceutical Contract Packaging Market Size Analysis and Outlook
- 7.1. North America Pharmaceutical Contract Packaging Market Overview, 2026
- 7.2. Key Industry Statistics, 2026
- 7.3. North America Pharmaceutical Contract Packaging Market Trends and Growth Opportunities to 2032
- 7.4. North America Pharmaceutical Contract Packaging Market Size Outlook by Type
- 7.5. North America Pharmaceutical Contract Packaging Market Size Outlook by Application
- 7.6. North America Pharmaceutical Contract Packaging Market Size Outlook by Country
- 7.7. United States
- 7.7.1. Key Statistics
- 7.7.2. The US Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 7.7.3. Key Factors Driving the US Pharmaceutical Contract Packaging Market Companies
- 7.8. Canada
- 7.8.1. Key Statistics
- 7.8.2. Canada Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 7.8.3. Key Factors Driving Canada Pharmaceutical Contract Packaging Market Companies
- 7.9. Mexico
- 7.9.1. Key Statistics
- 7.9.2. Mexico Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 7.9.3. Key Factors Driving Mexico Pharmaceutical Contract Packaging Market Companies
- Chapter 8- Europe Pharmaceutical Contract Packaging Market Size Analysis and Outlook
- 8.1. Europe Pharmaceutical Contract Packaging Market Overview, 2026
- 8.2. Key Industry Statistics, 2026
- 8.3. Europe Pharmaceutical Contract Packaging Market Trends and Growth Opportunities to 2032
- 8.4. Europe Pharmaceutical Contract Packaging Market Size Outlook by Type
- 8.5. Europe Pharmaceutical Contract Packaging Market Size Outlook by Application
- 8.6. Europe Pharmaceutical Contract Packaging Market Size Outlook by Country
- 8.7. Germany
- 8.7.1. Key Statistics
- 8.7.2. Germany Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 8.7.3. Key Factors Driving Germany Pharmaceutical Contract Packaging Market Companies
- 8.8. France
- 8.8.1. Key Statistics
- 8.8.2. France Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 8.8.3. Key Factors Driving France Pharmaceutical Contract Packaging Market Companies
- 8.9. United Kingdom
- 8.9.1. Key Statistics
- 8.9.2. United Kingdom Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 8.9.3. Key Factors Driving the UK Pharmaceutical Contract Packaging Market Companies
- 8.10. Spain
- 8.10.1. Key Statistics
- 8.10.2. Spain Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 8.10.3. Key Factors Driving Spain Pharmaceutical Contract Packaging Market Companies
- 8.11. Italy
- 8.11.1. Key Statistics
- 8.11.2. Italy Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 8.11.3. Key Factors Driving Italy Pharmaceutical Contract Packaging Market Companies
- 8.12. Rest of Europe
- 8.12.1. Key Statistics
- 8.12.2. Rest of Europe Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 8.12.3. Key Factors Driving Rest of Europe Pharmaceutical Contract Packaging Market Companies
- Chapter 9- Asia Pacific Pharmaceutical Contract Packaging Market Size Analysis and Outlook
- 9.1. Asia Pacific Pharmaceutical Contract Packaging Market Overview, 2026
- 9.2. Key Industry Statistics, 2026
- 9.3. Asia Pacific Pharmaceutical Contract Packaging Market Trends and Growth Opportunities to 2032
- 9.4. Asia Pacific Pharmaceutical Contract Packaging Market Size Outlook by Type
- 9.5. Asia Pacific Pharmaceutical Contract Packaging Market Size Outlook by Application
- 9.6. Asia Pacific Pharmaceutical Contract Packaging Market Size Outlook by Country
- 9.7. China
- 9.7.1. Key Statistics
- 9.7.2. China Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 9.7.3. Key Factors Driving China Pharmaceutical Contract Packaging Market Companies
- 9.8. Japan
- 9.8.1. Key Statistics
- 9.8.2. Japan Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 9.8.3. Key Factors Driving Japan Pharmaceutical Contract Packaging Market Companies
- 9.9. India
- 9.9.1. Key Statistics
- 9.9.2. India Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 9.9.3. Key Factors Driving India Pharmaceutical Contract Packaging Market Companies
- 9.10. South Korea
- 9.10.1. Key Statistics
- 9.10.2. South Korea Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 9.10.3. Key Factors Driving South Korea Pharmaceutical Contract Packaging Market Companies
- 9.11. Australia
- 9.11.1. Key Statistics
- 9.11.2. Australia Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 9.11.3. Key Factors Driving Australia Pharmaceutical Contract Packaging Market Companies
- 9.12. Southeast Asia
- 9.12.1. Key Statistics
- 9.12.2. Southeast Asia Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 9.12.3. Key Factors Driving Southeast Asia Pharmaceutical Contract Packaging Market Companies
- Chapter 10- South and Central America Pharmaceutical Contract Packaging Market Size Analysis and Outlook
- 10.1. South and Central America Pharmaceutical Contract Packaging Market Overview, 2026
- 10.2. Key Industry Statistics, 2026
- 10.3. South and Central America Pharmaceutical Contract Packaging Market Trends and Growth Opportunities to 2032
- 10.4. South and Central America Pharmaceutical Contract Packaging Market Size Outlook by Type
- 10.5. South and Central America Pharmaceutical Contract Packaging Market Size Outlook by Application
- 10.6. South and Central America Pharmaceutical Contract Packaging Market Size Outlook by Country
- 10.7. Brazil
- 10.7.1. Key Statistics
- 10.7.2. Brazil Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 10.7.3. Key Factors Driving Brazil Pharmaceutical Contract Packaging Market Companies
- 10.8. Argentina
- 10.8.1. Key Statistics
- 10.8.2. Argentina Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 10.8.3. Key Factors Driving Argentina Pharmaceutical Contract Packaging Market Companies
- 10.9. Rest of Latin America
- 10.9.1. Key Statistics
- 10.9.2. Rest of Latin America Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 10.9.3. Key Factors Driving Rest of Latin America Pharmaceutical Contract Packaging Market Companies
- Chapter 11- Middle East and Africa Pharmaceutical Contract Packaging Market Size Analysis and Outlook
- 11.1. Middle East and Africa Pharmaceutical Contract Packaging Market Overview, 2026
- 11.2. Key Industry Statistics, 2026
- 11.3. Middle East and Africa Pharmaceutical Contract Packaging Market Trends and Growth Opportunities to 2032
- 11.4. Middle East and Africa Pharmaceutical Contract Packaging Market Size Outlook by Type
- 11.5. Middle East and Africa Pharmaceutical Contract Packaging Market Size Outlook by Application
- 11.6. Middle East and Africa Pharmaceutical Contract Packaging Market Size Outlook by Country
- 11.7. Saudi Arabia
- 11.7.1. Key Statistics
- 11.7.2. Saudi Arabia Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 11.7.3. Key Factors Driving Saudi Arabia Pharmaceutical Contract Packaging Market Companies
- 11.8. United Arab Emirates
- 11.8.1. Key Statistics
- 11.8.2. The UAE Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 11.8.3. Key Factors Driving the UAE Pharmaceutical Contract Packaging Market Companies
- 11.9. Africa
- 11.9.1. Key Statistics
- 11.9.2. Africa Pharmaceutical Contract Packaging Market Size Outlook, 2021- 2032
- 11.9.3. Key Factors Driving Africa Pharmaceutical Contract Packaging Market Companies
- Chapter 12- Company Profiles
- 12.1. Top Companies in Pharmaceutical Contract Packaging Industry
- Catalent, Inc.
- Thermo Fisher Scientific (Patheon)
- Lonza Group
- Sharp (UPMC Group)
- Nipro Corporation
- Pfizer CentreOne
- Recipharm AB
- Vetter Pharma
- Almac Group
- PCI Pharma Services
- 12.2. Business Description
- 12.3. SWOT Profiles
- 12.4. Products and Services
- Chapter 13- Appendix
- Glossary of Terms
- Research Methodology & Data Sources
- Conclusion & Strategic Recommendations
- FAQs
- What is the current market size of Pharmaceutical Contract Packaging Market in 2026?
- The global Pharmaceutical Contract Packaging Market revenue generated a revenue of $38.2 Billion in 2025.
- What is the forecast growth rate for Pharmaceutical Contract Packaging Markets”
- Pharmaceutical Contract Packaging Market size is forecast to register a CAGR of 6.2% between 2026 and 2032.
- Which region is expected to grow the fastest through 2032?
- Asia Pacific is poised to register the fastest growth rate over the forecast period
- What are the leading market segments over the forecast period?
- By Service Type (Primary Packaging, Secondary Packaging, Tertiary Packaging, By Packaging Format (Blister Packs, Bottles, Vials and Ampoules, Pre-filled Syringes and Cartridges, Sachets and Stick Packs, Punches and Pouches, By Material Type (Plastics and Polymers, Paper and Paperboard, Glass, Aluminum Foil, Other Materials, By Drug Formulation (Solid Dosage, Liquid Dosage, Injectable / Parenteral, Semi-Solid Dosage, By End-User (Big Pharma, Generics and Biosimilar Companies, Emerging Biotech and Start-ups, CROs and CDMOs)
- Who are the top companies in the global Pharmaceutical Contract Packaging Industry?
- Catalent, Inc., Thermo Fisher Scientific (Patheon), Lonza Group, Sharp (UPMC Group), Nipro Corporation, Pfizer CentreOne, Recipharm AB, Vetter Pharma, Almac Group, PCI Pharma Services
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
